The effect of type 2 diabetes mellitus and obesity on muscle progenitor cell function

被引:0
|
作者
Shuzhi Teng
Ping Huang
机构
[1] Jilin University,The Key Laboratory of Pathobiology, Ministry of Education, Norman Bethune College of Medicine
来源
Stem Cell Research & Therapy | / 10卷
关键词
Satellite cell; muscle progenitor cell; T2DM; Obesity;
D O I
暂无
中图分类号
学科分类号
摘要
In addition to its primary function to provide movement and maintain posture, the skeletal muscle plays important roles in energy and glucose metabolism. In healthy humans, skeletal muscle is the major site for postprandial glucose uptake and impairment of this process contributes to the pathogenesis of type 2 diabetes mellitus (T2DM). A key component to the maintenance of skeletal muscle integrity and plasticity is the presence of muscle progenitor cells, including satellite cells, fibroadipogenic progenitors, and some interstitial progenitor cells associated with vessels (myo-endothelial cells, pericytes, and mesoangioblasts). In this review, we aim to discuss the emerging concepts related to these progenitor cells, focusing on the identification and characterization of distinct progenitor cell populations, and the impact of obesity and T2DM on these cells. The recent advances in stem cell therapies by targeting diabetic and obese muscle are also discussed.
引用
收藏
相关论文
共 50 条
  • [41] SURFACTANT PROTEIN D LEVELS WITH OBESITY AND TYPE 2 DIABETES MELLITUS
    Alkwai, Hend
    Aboelnaga, Shimaa Mohammad
    Hussain, Rania Abdeen
    Khatoon, Fahmida
    GOMAL JOURNAL OF MEDICAL SCIENCES, 2020, 18 (01): : 39 - 42
  • [42] Complement activation in obesity, insulin resistance, and type 2 diabetes mellitus
    Shim, Kyumin
    Begum, Rayhana
    Yang, Catherine
    Wang, Hongbin
    WORLD JOURNAL OF DIABETES, 2020, 11 (01) : 1 - 12
  • [43] Obesity and the risk of type 2 diabetes mellitus and certain types of cancer
    Karnafel, Waldemar
    Mozejko-Pastewka, Barbara
    CLINICAL DIABETOLOGY, 2015, 4 (04): : 163 - 171
  • [44] Fibrogenesis in Fatty Liver Associated with Obesity and Diabetes Mellitus Type 2
    Kaz Jaskiewicz
    Robert Rzepko
    Zbigniew Sledzinski
    Digestive Diseases and Sciences, 2008, 53 : 785 - 788
  • [45] Update on the epidemiology of obesity and type 2 diabetes mellitus in France.
    Charles, MA
    DIABETES & METABOLISM, 2000, 26 : 17 - 20
  • [46] New endoscopic procedures for diabetes mellitus type 2 and obesity treatment
    Frattini, Francesco
    Borroni, Giacomo
    Lavazza, Matteo
    Liu, Xiaoli
    Kim, Hoon Yub
    Liu, Renbin
    Anuwong, Angkoon
    Rausei, Stefano
    Dionigi, Gianlorenzo
    GLAND SURGERY, 2016, 5 (05) : 458 - 464
  • [47] Anti-obesity drugs in the treatment of type 2 diabetes mellitus
    Quevedo, J.
    Tur, J.
    Serra, G.
    Burguera, B.
    AVANCES EN DIABETOLOGIA, 2010, 26 (03): : 161 - 166
  • [48] Association of Obesity Indicators with Hypertension in Type 2 Diabetes Mellitus Patients
    Chaudhary, Ghulam Mohyud Din
    Din, Asim Tameez Ud
    Chaudhary, Farooq Mohyud Din
    Tanveer, Azfar
    Siddiqui, Khaleeq H.
    Din, Asma Tameez Ud
    Chaudhary, Noman A.
    Chaudhary, Sana Mohyud Din
    Tameez-ud-din, Ahsan
    Nawaz, Faisal
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (07)
  • [49] Revised Protein Sparing Diet in Obesity and Type 2 Diabetes Mellitus
    Cincione, Raffaele Ivan
    Losavio, Francesca
    Cibelli, Giuseppe
    Messina, Giovanni
    Polito, Rita
    Casula, Elias
    Cincione, Pamela Pia
    Amatruda, Marco
    Limone, Pierpaolo
    NUTRIENTS, 2022, 14 (24)
  • [50] Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments
    Ruze, Rexiati
    Liu, Tiantong
    Zou, Xi
    Song, Jianlu
    Chen, Yuan
    Xu, Ruiyuan
    Yin, Xinpeng
    Xu, Qiang
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14